Michal Berkner

Partner
Full contact info

Experience

Clinical Microbiomics and CosmosID Merge To Create Global Leader in Microbiome Research Services

October 11, 2023

Cooley advised Clinical Microbiomics, a leading innovator in bioinformatics and systems biology for the microbiome field based in Copenhagen, on its merger with CosmosID, a leading CLIA-certified, GxP-compliant microbiome contract research organization based in Maryland. 

Read more

Related contacts

Michal Berkner
Partner, London
Rita Sobral
Associate, London
Sydney Sawyier
Associate, London
Vlad Herta
Associate, London

Related Practices & Industries

VectivBio to be Acquired by Ironwood

May 23, 2023

Cooley advised VectivBio, a clinical-stage biotech company focused on the discovery and development of treatments for severe, rare gastrointestinal (GI) conditions, on its acquisition by Ironwood, with an estimated aggregate consideration of approximately $1 billion.

Read more

Related contacts

Michal Berkner
Partner, London
Brandon W. Fenn
Partner, New York
Rita Sobral
Associate, London
Sydney Sawyier
Associate, London
Vlad Herta
Associate, London
Sarah Curry
Associate, New York
Trevor Bossi
Associate, Boston
Lois NaYeon Yoo
Associate, New York
Ofir Hadari
Associate, New York
David Burns
Special Counsel, Washington DC
Jacqueline Grise
Partner, Washington DC
Nicollette R. Kirby
Associate, Washington DC
Barbara Mirza
Partner, Los Angeles Santa Monica
Mary Maher Lewis
Special Counsel, Reston
Steven A. Zuckerman
Associate, New York
Stephanie Gentile
Partner, New York
Eileen Marshall
Partner, Washington DC
Rick Jantz
Associate, Los Angeles Santa Monica
Ivor Elrifi
Partner, New York
Heidi A. Erlacher
Partner, Boston
Phil Mitchell
Partner, New York
Natasha Leskovsek
Of Counsel, Washington DC
Megan Flynn
Associate, London
Joe Claffey
Associate, London
Anthony Hajj
Associate, New York

Related Practices & Industries

Redx Pharma to Merge With Jounce Therapeutics

March 6, 2023

Cooley advised Redx Pharma, a UK clinical-stage biotechnology company, on its all share merger with Jounce Therapeutics, a US clinical-stage immunotherapy company, in a $425 million and contingent value right transaction.

Related contacts

Michal Berkner
Partner, London
Claire Keast-Butler
Partner, London
Russell Anderson
Associate, London
Rita Sobral
Associate, London
Natasha Kaye
Partner, London
Nicola Squire
Partner, London
Aaron Pomeroy
Partner, Colorado
Megan Browdie
Partner, Washington DC
Caroline Hobson
Partner, London
Paula Holland
Partner, London
David Wilson
Partner, London
Josh Kaufman
Partner, New York
Laurence Harris
Partner, London
Chris Stack
Partner, London
Jeff Goldman
Special Counsel, Palo Alto
Sharon Connaughton
Special Counsel, Washington DC
Stacey A. Bradford
Special Counsel, Washington DC
Charlotte Irvine
Associate, London
Vlad Herta
Associate, London
Bethan Chalmers
Associate, London
Dov Fiskus
Associate, New York
Amanda Griggs
Associate, New York
Anna Caro
Associate, London
Rick Jantz
Associate, Los Angeles Santa Monica
Dionne A. Thomas
Associate, San Diego

Bavarian Nordic Acquires Emergent BioSolutions Travel Vaccines Portfolio

February 22, 2023

Bavarian Nordic, a vaccine company, has entered into a definitive agreement to acquire Emergent BioSolutions’ travel vaccines portfolio for up to $380 million, including an upfront payment of $270 million.

Read more

Related contacts

Michal Berkner
Partner, London
John Wilkinson
Partner, London
Jarrett Burks
Associate, London
Joe Sandys
Associate, London
Michael Fernando
Associate, London
Sydney Sawyier
Associate, London

Biote Agrees to Combine With SPAC Haymaker Acquisition Corp. III

December 16, 2021

Cooley advised Biote, a medical practice-building business within the hormone optimization space, on its definitive business combination agreement with special purpose acquisition company (SPAC) Haymaker Acquisition Corp III. Lawyers Michal Berkner and Jarrett Burks led the Cooley team advising Biote.

Related contacts

Michal Berkner
Partner, London
Jarrett Burks
Associate, London
Vlad Herta
Associate, London
Ryan Sansom
Partner, Boston
Meg Begur
Associate, London
Timothy Shapiro
Partner, Palo Alto
Eileen Marshall
Partner, Washington DC
Jeff Goldman
Special Counsel, Palo Alto
Sonia Nath
Partner, Washington DC
Michael Tollini
Partner, Washington DC
Phil Mitchell
Partner, New York
Wyatt Kernell
Associate, New York
Mischi a Marca
Partner, San Francisco
Kathleen Goodhart
Partner, San Francisco
Ehijele Olumese
Associate, Los Angeles Downtown
Francis Wheeler
Partner, Colorado
Charlotte Drew
Associate, Boston
Claire Keast-Butler
Partner, London
Andrew Epstein
Special Counsel, Seattle
Todd Gluth
Partner, San Diego
Joseph Lockinger
Special Counsel, Washington DC
Stacey A. Bradford
Special Counsel, Washington DC
David Hopkins
Special Counsel, Colorado
Ross Eberly
Partner, Los Angeles Santa Monica
Moussa O. Ismail
Associate, Reston

Related Practices & Industries

View more

Rankings & accolades

The Legal 500 UK: M&A (2022)

Chambers & Partners (UK): Leading Individual - Corporate/ M&A (2022)

Outstanding. Smart, can-do and entrepreneurial attitude. Always available, very commercial, and a pleasure to work with.

Legal 500, Corporate & Commercial M&A, 2023